May 22, 2017 08:30 AM Eastern Daylight Time BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today announced the publication of Phase III data demonstrating the efficacy and safety of CINGAL®, its novel HA-corticosteroid […]